Transforming Early Cancer Detection with Liquid Biopsy, Automation, and AI
Swathi Kodaikal, MSc
The liquid biopsy market is expected to increase by approximately 20 percent between 2022 and 2032
cell-free DNA
Elevating Cancer Diagnostics and Treatment Using Epigenetics
Moshe Szyf, PhD
Integrating epigenetic insights into cancer research could help deliver personalized, high-quality, and cost-effective patient care
Labcorp Accelerates Molecular Residual Disease Research
LabCorp
The Plasma Detect™ is the first clinically validated, whole-genome sequencing MRD solution for early-stage colon cancer
ctDNA Predicts Therapy Response in Gastroesophageal Cancer Cases
Johns Hopkins Medicine
Liquid biopsy helps screen for ctDNA, which is linked to how patients respond to immuno- and chemo-therapy
Detecting Cancers Earlier Using ML and Fragmentomics
City of Hope
The innovative approach could help clinicians identify cancer in patients sooner and using smaller blood draws
New Prediction Model Aids in Early Detection of Preeclampsia
Swathi Kodaikal, MSc
The model analyzes methylation changes in the cell-free DNA of pregnant women at risk of preeclampsia
Diagnose Critical Infections by Detecting mcfDNA in Plasma With the Karius Test
Today's Clinical Lab, Karius
Join Today's Clinical Lab and Nicole Coufal, MD, PhD, to discuss the single blood test diagnosing multiple infections in pediatric patients
NIPS More than 99 Percent Accurate in Detecting Common Genetic Abnormalities
Rachel Muenz
A recently-published review found that NIPS tests accurately detect common genetic conditions in general-risk pregnancies
Enhanced PCR Capabilities with Digital PCR
Kristin Fathe, PhD
High Definition PCR can expand the multiplexing of digital PCR tenfold
A Microfluidic Gated Device for Extraction of Cell-Free DNA
Shibaura Institute of Technology
Scientists develop a microfluidic device for the purification of genomic DNA fragments from human-plasma samples